T 2332/14 (Diagnosis and treatment of epithelial-derived cancers/UCB PHARMA) of 08.01.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T233214.20200108
- Date of decision
- 8 January 2020
- Case number
- T 2332/14
- Petition for review of
- -
- Application number
- 02779771.1
- IPC class
- G01N 33/574
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- METHODS FOR DIAGNOSIS AND TREATMENT OF EPITHELIAL-DERIVED CANCERS, SUCH AS COLORECTAL CANCERS AND KIDNEY CANCERS
- Applicant name
- UCB Pharma S.A.
- Opponent name
- Seattle Genetics, Inc.
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention R 84(1)
- Keywords
- Lapse of patent in all designated states - termination of appeal proceedings
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal proceedings are terminated.